Affinivax, Inc. — Form D
Affinivax, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-05. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-05
- Form: D
- Accession: 0001726931-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 5
- Date of first sale: 2017-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302491
Issuer
- Name: Affinivax, Inc.
- CIK: 0001726931
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 301 BINNEY STREET, CAMBRIDGE, MA, 02142
- Phone: 617-863-3672
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Kamran Tavangar | Executive Officer | North Cambridge, MA |
| Steven Altschuler | Director | WATERTOWN, MA |
| Richard Malley | Director | WATERTOWN, MA |
| George Siber | Director | Irvine, CA |
| Andrew Hack | Director | CAMPBELL, CA |
| Robert More | Director | Carlsbad, CA |
| Frances Heller | Director | Cambridge, MA |
| Steven Brugger | Director | Cambridge, MA |
| Steven Brugger | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More